EDAP TMS reported EUR-4.92M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AngioDynamics USD 5.94M 3.78M Sep/2025
Boston Scientific USD 1.16B 213M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Henry Schein USD 289M 2M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Veracyte USD 42.8M 488K Mar/2026